MidWestOne Financial Group’s Alexion Pharmaceuticals ALXN Stock Holding History

MidWestOne Financial Group’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-12,127	Closed	-$1.89M	–	230
2020 Q4	$1.89M	Buy	12,127 +1,232	+11%	+$158K	0.52%	41
2020 Q3	$1.25M	Buy	10,895 +1,548	+17%	+$167K	0.41%	60
2020 Q2	$1.05M	Buy	9,347 +2,078	+29%	+$221K	0.44%	41
2020 Q1	$653K	Buy	7,269 +1,537	+27%	+$151K	0.24%	99
2019 Q4	$619K	Buy	5,732 +364	+7%	+$38.9K	0.13%	131
2019 Q3	$526K	Buy	5,368 +371	+7%	+$41.8K	0.16%	136
2019 Q2	$655K	Buy	+4,997	New	+$644K	0.18%	138

Other funds holding ALXN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MidWestOne Financial Group's ALXN Position: Q1 2021 in Review

MidWestOne Financial Group sold out of Alexion Pharmaceuticals (ALXN) in Q1 2021, closing a stake of 12,127 shares — an estimated $1.89M sold.

MidWestOne Financial Group first reported a position in ALXN in Q2 2019 and held it in 7 quarters. The position peaked at $1.89M in Q4 2020. 754 funds tracked by Wall St. Rank hold ALXN as of Q1 2021.

MidWestOne Financial Group reported no remaining Alexion Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
MidWestOne Financial Group sold 12,127 Alexion Pharmaceuticals shares in Q1 2021, an estimated $1.89M.
MidWestOne Financial Group first reported a position in Alexion Pharmaceuticals in Q2 2019 and held it in 7 quarters.
MidWestOne Financial Group's Alexion Pharmaceuticals position peaked at $1.89M in Q4 2020.
754 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2021.

Based on MidWestOne Financial Group's 13F filing for Q1 2021, filed 18 May 2021.